PICO Portalanswers from OpenAlex
ActionAid
InstitutionResearch output, impact & collaborations
ActionAid is a institution indexed in PICO Portal from OpenAlex.
What is known about ActionAid?
PICO Portalrecord summary
ActionAid is a research organisation in Washington D.C., US. OpenAlex records 1,815 works and 64,972 citations for it. 712 researchers list it as their most recent affiliation.
How many works does ActionAid have?
PICO Portalindexed works
ActionAid has 1,815 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does ActionAid have?
PICO Portalcitation count
ActionAid has 64,972 citations in the OpenAlex counts PICO Portal stores.
How many researchers are at ActionAid?
PICO Portalresearcher count
ActionAid has 712 researchers in the PICO Portal index.
What is the average h-index at ActionAid?
PICO Portalavg h-index
ActionAid has an average h-index of 28 in OpenAlex.
What is the ROR of ActionAid?
PICO Portalror
The ROR for ActionAid is on the source record.
What is the OpenAlex record for ActionAid?
PICO Portalopenalex
The OpenAlex for ActionAid is on the source record.
What is the Wikidata of ActionAid?
PICO Portalwikidata
The Wikidata for ActionAid is on the source record.
Who are the most-cited researchers behind ActionAid?
PICO Portaltop researchers by citations
What are the most-cited papers on ActionAid?
PICO Portalmost cited works
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham, Eiji Higashihara, Ronald D. Perrone, Holly B. Krasa, John Ouyang, Frank S. Czerwiec
Prevalence of autosomal dominant polycystic kidney disease in the European Union
Cynthia Willey, Jaime D. Blais, Anthony K Hall, Holly B. Krasa, Andrew Makin, Frank S. Czerwiec
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
Paul B. Watkins, James H. Lewis, Neil Kaplowitz, David Alpers, Jaime D. Blais, Dan M. Smotzer, Holly B. Krasa, John Ouyang, Vicente E. Torres, Frank S. Czerwiec, Christopher A. Zimmer
Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction
James E. Udelson, Cesare Orlandi, John Ouyang, Holly B. Krasa, Christopher A. Zimmer, Geir Frivold, W. Herbert Haught, Sheiba Meymandi, Cezar Macarie, Dimitar Raef, Patricia Wedge, Marvin A. Konstam, Mihai Gheorghiade
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure
John E. Blair, Faı̈ez Zannad, Marvin A. Konstam, Thomas D. Cook, Brian Traver, John C. Burnett, Liliana Grinfeld, Holly B. Krasa, Aldo P. Maggioni, Cesare Orlandi, Karl Swedberg, James E. Udelson, Christopher Zimmer, Mihai Gheorghiade
How much of the research on ActionAid is open access?
PICO Portalopen access share
82%OPEN ACCESS